Advanced agentic AI technology digitizes, automates, and adds intelligence to every aspect of trial creation.
We see a world where optimized studies feed upstream and downstream artifacts and systems resulting in increased efficiency, shorter timelines and better outcomes – because patients don't have time to wait!
Build complete clinical studies with intelligent automation and AI-powered recommendations. From study setup to schedule finalization, streamline every step of the design process.
Explore Smart Designer →Reusable knowledge and language in a contextually relevant manner. Access your organization's collective wisdom instantly.
Explore →500K+ BFO-compliant classes. A shared semantic framework connecting clinical study concepts across documents and systems.
Explore →Rapid document digitization and data ingestion via NLP, NER, and LLMs. Transform legacy protocols and study documents into structured, queryable data assets.
Explore Banzai →Expert guidance across clinical science, biostatistics, regulatory strategy, and medical writing... helping you optimize study design in real time.
Most tools focus on writing protocols. Franklin focuses on improving the design decisions that shape the protocol.
Explore alternatives across endpoints, eligibility criteria, schedules of activities, patient populations, and operational complexity - before they become locked into downstream documents.
Franklin is powered by structured study data connected through the Trials.ai ontology and Dynamic Data Graph.
This enables Franklin to reason across historical clinical trials, operational outcomes, and protocol design patterns to surface meaningful design insights. Not just text generation.
Study design requires expertise across clinical science, biostatistics, regulatory strategy, protocol development, and clinical operations.
Franklin brings those perspectives into a single intelligence layer to help teams evaluate tradeoffs across scientific, statistical, and operational dimensions.
ZS is committed to transforming clinical development through technology, data science, and deep domain expertise - partnering with the world's leading life sciences companies to bring therapies to patients faster.